| 000 | 01667 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513200228.0 | ||
| 264 | 0 | _c20000119 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1023/a:1006229701954 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKucuk, O | |
| 245 | 0 | 0 |
_aPhase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185). _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cSep 1999 |
||
| 300 |
_a201-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPandya, K J | |
| 700 | 1 | _aSkeel, R T | |
| 700 | 1 | _aHochster, H | |
| 700 | 1 | _aAbeloff, M D | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 57 _gno. 2 _gp. 201-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1006229701954 _zAvailable from publisher's website |
| 999 |
_c10554120 _d10554120 |
||